title: Selection of resistance mutations in children receiving prophylaxis with lamivudine or nevirapine for the prevention of postnatal transmission of HIV.
authors.forename: Marina
authors.initials: M
authors.lastname: Giuliano
authors.forename: Clementina M
authors.initials: CM
authors.lastname: Galluzzo
authors.forename: Elena A P
authors.initials: EA
authors.lastname: Germinario
authors.forename: Roberta
authors.initials: R
authors.lastname: Amici
authors.forename: Luciana
authors.initials: L
authors.lastname: Bassani
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Dehò
authors.forename: Joseph
authors.initials: J
authors.lastname: Vyankandondera
authors.forename: Francis
authors.initials: F
authors.lastname: Mmiro
authors.forename: Pius
authors.initials: P
authors.lastname: Okong
authors.forename: Stefano
authors.initials: S
authors.lastname: Vella
mesh_terms: D024882:Drug Resistance, Viral / Q000235:genetics; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control / Q000635:transmission; D016333:HIV Protease / Q000235:genetics; D015497:HIV-1 / Q000187:drug effects / Q000235:genetics*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D019259:Lamivudine / Q000494:pharmacology / Q000627:therapeutic use*; D009154:Mutation; D019829:Nevirapine / Q000494:pharmacology / Q000627:therapeutic use*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000821:virology; D012194:RNA-Directed DNA Polymerase / Q000235:genetics; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D012432:Rwanda; D012641:Selection, Genetic; D013045:Species Specificity; D016896:Treatment Outcome; D014454:Uganda
chemical_list: D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D019829:Nevirapine; D012194:RNA-Directed DNA Polymerase; D016333:HIV Protease